Skip to the page

Data / Form D filings / ARCHIMEDES PHARMA Ltd

ARCHIMEDES PHARMA Ltd: Form D filing

ARCHIMEDES PHARMA Ltd, a pharmaceuticals company in Reading, United Kingdom, filed a Form D with the SEC in 2010. The latest, on May 17, 2010, reports an offering of $15,240 with nothing sold yet.

Find out what ARCHIMEDES PHARMA Ltd does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
250 SOUTH OAK WAY, GREEN PARK, Reading, United Kingdom, RG2 6
Phone
44 1189 31 5050
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
United Kingdom
Revenue range
Decline to Disclose
Exemptions claimed
Rule 504
SEC identifier (CIK)
1491425

The full lists. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
May 17, 2010New notice$15,240$0$15,2400Yet to occursec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Goran AndoDirector
Piyush ShuklaDirector
Ulrik SporkDirector
Simon TurtonDirector
Jeffrey BuchalterExecutive Officer

Every Form D from the week of May 17, 2010 · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what ARCHIMEDES PHARMA Ltd reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.